In HNSCC, HA binding to CD44 was found to increase CSCs numbers by PI3K–4EBP1–SOX2, whereas CD44 binding to VCAM‐1 contribute to invasiveness by ezrin/PI3K. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.